Drugs and Cosmetic Rules, 1945

The Drugs and Cosmetics Rules, 1945, were established by the Government of India to implement the Drugs and Cosmetics Act, 1940. These rules, along with the Act, form a comprehensive regulatory framework aimed at controlling the import, manufacture, distribution, and sale of drugs and cosmetics within India. The primary objective is to ensure that all such products available in the country are safe, effective, and meet specified quality standards.

Key aspects of the Drugs and Cosmetics Rules, 1945, include:

Classification and Guidelines

The rules classify drugs into various schedules and provide detailed guidelines for their storage, sale, display, and prescription.

Scope

They cover all medicines for internal and external use by humans or animals, as well as substances intended for diagnosis, treatment, or prevention of diseases, and cosmetics.

Regulatory Mechanisms

The rules mandate licensing for manufacturing and distribution, establish quality control and testing procedures, and led to the formation of advisory bodies such as the Drugs Technical Advisory Board (DTAB) and Drugs Consultative Committees (DCC). They also define standards of quality and address issues like misbranding, adulteration, and spurious products.

Schedules

The rules are structured into 19 Parts and 20 schedules, each detailing specific requirements for different categories of drugs and products. Some notable schedules include:

  • Schedule G: Pertains to drugs like hormonal medications, antineoplastic drugs, anticonvulsants, hypoglycemic drugs, and antihistamines.
  • Schedule H: Lists prescription drugs that cannot be sold without a prescription from a Registered Medical Practitioner.
  • Schedule J: Enlists diseases and medical conditions for which no drug can legally claim a cure.
  • Schedule X: Covers addictive drugs (narcotics, psychotropics) that require strict storage under lock and key and a prescription.
  • Schedule T: Contains regulations for the manufacture of Ayurvedic, Siddha, and Unani drugs.
  • Schedule Y: Outlines requirements and guidelines for clinical trials.